Publications by authors named "Alberta Locatelli"

Claim this Profile
D
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.
Maurizio Callari, Matteo Dugo, Marco Barreca, Balázs Győrffy, Barbara Galbardi, Alberta Locatelli

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
Carlo Bosi, Áron Bartha, Barbara Galbardi, Giulia Notini, Matteo M Naldini, Alberta Locatelli

Eur J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of a standardized preparation of methotrexate, cytarabine, and methylprednisolone hemisuccinate for intrathecal use.
Gianluca Perego, Giorgia Longobardo, Lucia Viganò, Alberta Locatelli, Cinzia Veneziano

J Oncol Pharm Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer.
Lucia Viganò, Alberta Locatelli, Adele Ulisse, Barbara Galbardi, Matteo Dugo

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr phosphorylation.
Marco Gaviraghi, Andrea Rabellino, Annapaola Andolfo, Matthias Brand, Chiara Brombin, Alberta Locatelli

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr phosphorylation.
Marco Gaviraghi, Andrea Rabellino, Annapaola Andolfo, Matthias Brand, Chiara Brombin, Alberta Locatelli

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Luisa Pascucci, Valentina Coccè, Arianna Bonomi, Diletta Ami, Piero Ceccarelli, Alberta Locatelli

J Control Release· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer.
Henri Roché, Elena De Benedictis, Ewa Cottura, Silvia Govi, Florence Dalenc, Alberta Locatelli

Clin Breast Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Augusto Pessina, Arianna Bonomi, Valentina Coccè, Gloria Invernici, Stefania Navone, Alberta Locatelli

PLoS One· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.
Antonella Perotti, Alberta Locatelli, Cristiana Sessa, Dagmar Hess, Lucia Viganò

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.
Roberta Frapolli, Massimo Zucchetti, Cristiana Sessa, Silvia Marsoni, Lucia Viganò, Alberta Locatelli

Eur J Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TRAIL agonistic receptors for cancer therapy.
Carmelo Carlo-Stella, Cristiana Lavazza, Alberta Locatelli, Lucia Viganò, Alessandro M Gianni

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing.
Cristiana Sessa, Lucia Viganò, Giacomo Grasselli, Josè Trigo, Irene Marimon, Alberta Locatelli

Eur J Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.
Anja Henningsson, Sharon Marsh, Walter J Loos, Mats O Karlsson, Adam Garsa, Alberta Locatelli

Clin Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthracyclines.
Luca Gianni, Giacomo Grasselli, Sara Cresta, Alberta Locatelli, Lucia Viganò

Cancer Chemother Biol Response Modif· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level.
Manuela Campiglio, Alberta Locatelli, Clelia Olgiati, Nicola Normanno, Giulia Somenzi

J Cell Physiol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer.
Giulia Bianchi, John Albanell, Wolfgang Eiermann, Giordano Vitali, David Borquez, Alberta Locatelli

Clin Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthracyclines.
Luca Gianni, Giacomo Grasselli, Sara Cresta, Alberta Locatelli, Lucia Viganò

Cancer Chemother Biol Response Modif· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis